Citation: | SHAO Yu-rou, WANG Yu-tong, CHEN Zhi-peng. Surface Modification Strategies of Extracellular Vesicles and Their Applications in Natural Products Delivery[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 561-566. |
[1] |
KOWAL J,ARRAS G,COLOMBO M,et al.Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes[J].Proc Natl Acad Sci USA,2016,113(8):968-977.
|
[2] |
WILLMS E,CABANAS C,MAGER I,et al.Extracellular vesicle heterogeneity:subpopulations,isolation techniques,and diverse functions in cancer progression[J].Front Immunol,2018,9:738.
|
[3] |
ALAVI M,HAMIDI M.Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles[J].Drug Metab Pers Ther,2019,34(1):1-8.
|
[4] |
VISSER JG,VAN STADEN ADP,SMITH C.Harnessing macrophages for controlled-release drug delivery:Lessons from microbes[J].Front Pharmacol,2019,10:22.
|
[5] |
LUAN X,SANSANAPHONGPRICHA K,MYERS I,et al.Engineering exosomes as refined biological nanoplatforms for drug delivery[J].Acta Pharmacol Sin,2017,38(6):754-763.
|
[6] |
LI MY,JIANG M,MENG J,et al.Exosomes:Carriers of pro-fibrotic signals and therapeutic targets in fibrosis[J].Curr Pharm Des,2019,25(42):4496-4509.
|
[7] |
GOH WJ,ZOU S,ONG WY,et al.Bioinspired cell-derived nanovesicles versus exosomes as drug delivery systems:A cost-effective alternative[J].Sci Rep,2017,7(1):14322.
|
[8] |
GUDBERGSSON JM,JONSSON K,SIMONSEN JB,et al.Systematic review of targeted extracellular vesicles for drug delivery-considerations on methodological and biological heterogeneity[J].J Control Release,2019,306:108-120.
|
[9] |
FRIAND V,DAVID G,ZIMMERMANN P.Syntenin and syndecan in the biogenesis of exosomes[J].Biol Cell,2015,107(10):331-341.
|
[10] |
KAJIMOTO T,OKADA T,MIYA S,et al.Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes[J].Nat Commun,2013,4:2712.
|
[11] |
TRICARICO C,CLANCY J,D'SOUZA-SCHOREY C.Biology and biogenesis of shed microvesicles[J].Small GTPases,2017,8(4):220-232.
|
[12] |
LU M,HUANG Y.Bioinspired exosome-like therapeutics and delivery nanoplatforms[J].Biomaterials,2020,242:119925.
|
[13] |
JURJ A,ZANOAGA O,BRAICU C,et al.A comprehensive picture of extracellular vesicles and their contents.Molecular transfer to cancer cells[J].Cancers,2020,12(2):298.
|
[14] |
KOOIJMANS SA,VADER P,VAN DOMMELEN SM,et al.Exosome mimetics:A novel class of drug delivery systems[J].Int J Nanomedicine,2012,7:1525-1541.
|
[15] |
QIAO L,HU SQ,HUANG K,et al.Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs[J].Theranostics,2020,10(8):3474-3487.
|
[16] |
VANDERGRIFF A,HUANG K,SHEN DL,et al.Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide[J].Theranostics,2018,8(7):1869-1878.
|
[17] |
ANTES TJ,MIDDLETON RC,LUTHER KM,et al.Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display[J].J Nanobiotechnol,2018,16(1):61.
|
[18] |
DELCAYRE A,ESTELLES A,SPERINDE J,et al.Exosome Display technology:Applications to the development of new diagnostics and therapeutics[J].Blood Cells Mol Dis,2005,35(2):158-168.
|
[19] |
ARMSTRONG JP,HOLME MN,STEVENS MM.Re-engineering extracellular vesicles as smart nanoscale therapeutics[J].ACS Nano,2017,11(1):69-83.
|
[20] |
DANG XT,ZENG XR.Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases[J].Gene,2016,575(2):377-384.
|
[21] |
ALVAREZ-ERVITI L,SEOW Y,YIN HF,et al.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes[J].Nat Biotechnol,2011,29(4):341-345.
|
[22] |
OHNO S,TAKANASHI M,SUDO K,et al.Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells[J].Mol Ther,2013,21(1):185-191.
|
[23] |
WAN Y,WANG LX,ZHU CD,et al.Aptamer-conjugated extracellular nanovesicles for targeted drug delivery[J].Cancer Res,2018,78(3):798-808.
|
[24] |
KOOIJMANS SAA,GITZ-FRANCOIS JJJM,SCHIFFELERS RM,et al.Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: A plug-and-play approach[J].Nanoscale,2018,10(5):2413-2426.
|
[25] |
OTZEN DE,BLANS K,WANG HB,et al.Lactadherin binds to phosphatidylserine-containing vesicles in a two-step mechanism sensitive to vesicle size and composition[J].Biochim Biophys Acta,2012,1818(4):1019-1027.
|
[26] |
OUYANG T,LIU XH,OUYANG HS,et al.Recent trends in click chemistry as a promising technology for virus-related research[J].Virus Res,2018,256:21-28.
|
[27] |
ZOU Y,ZHANG L,YANG L,et al."Click" chemistry in polymeric scaffolds:Bioactive materials for tissue engineering[J].J Control Release,2018,273:160-179.
|
[28] |
SMYTH T,PETROVA K,PAYTON NM,et al.Surface functionalization of exosomes using click chemistry[J].Bioconjug Chem,2014,25(10):1777-1784.
|
[29] |
SATO YT,UMEZAKI K,SAWADA S,et al.Engineering hybrid exosomes by membrane fusion with liposomes[J].Sci Rep,2016,6:21933.
|
[30] |
DEHAINI D,WEI XL,FANG RH,et al.Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization[J].Adv Mater Weinheim,2017,29(16):1606209.
|
[31] |
HADLA M,PALAZZOLO S,CORONA G,et al.Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models[J].Nanomedicine,2016,11(18):2431-2441.
|
[32] |
CASCAO R,FONSECA JE,MOITA LF.Celastrol:A spectrum of treatment opportunities in chronic diseases[J].Front Med (Lausanne),2017,4:69.
|
[33] |
HEWLINGS SJ,KALMAN DS.Curcumin: A review of its' effects on human health[J].Foods,2017,6(10):92.
|
[34] |
SUN DM,ZHUANG XY,XIANG XY,et al.A novel nanoparticle drug delivery system:the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes[J].Mol Ther,2010,18(9):1606-1614.
|
[35] |
TIAN T,ZHANG HX,HE CP,et al.Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy[J].Biomaterials,2018,150:137-149.
|
[36] |
刘常园, 汤静, 赵立艳. 花青素的稳定性与功能研究进展[J]. 食品与营养科学, 2018, 7(1): 53-63.
|
[37] |
MUNAGALA R,AQIL F,JEYABALAN J,et al.Exosomal formulation of anthocyanidins against multiple cancer types[J].Cancer Lett,2017,393:94-102.
|
[38] |
SOLETI R,ANDRIANTSITOHAINA R,MARTINEZ MC.Impact of polyphenols on extracellular vesicle levels and effects and their properties as tools for drug delivery for nutrition and health[J].Arch Biochem Biophys,2018,644:57-63.
|
[39] |
AQIL F,KAUSAR H,AGRAWAL AK,et al.Exosomal formulation enhances therapeutic response of celastrol against lung cancer[J].Exp Mol Pathol,2016,101(1):12-21.
|
[40] |
LIU YP,ZHAO Y,WEI ZH,et al.Targeting thioredoxin system with an organosulfur compound,diallyl trisulfide (DATS),attenuates progression and metastasis of triple-negative breast cancer (TNBC)[J].Cell Physiol Biochem,2018,50(5):1945-1963.
|
[41] |
刘玉萍,傅荣萍,陈彦,等. 大蒜素二烯丙基三硫醚-外泌体抗小鼠黑色素瘤肺转移的作用[J].药学学报, 2019, 54(9): 1688-1694.
|
[42] |
AGRAWAL AK,AQIL F,JEYABALAN J,et al.Milk-derived exosomes for oral delivery of paclitaxel[J].Nanomed-Nanotechnol,2017,13(5):1627-1636.
|
[43] |
SALARPOUR S, PARDAKHTY A, AHMADI-ZEIDABADI M, et al. Exoxome-loaded Paclitaxel: preparation and toxicity evaluation on two glioblastoma cell lines [J]. Nanomed Res J, 2019, 4(4): 239-246.
|
[44] |
KIM MS, HANEY MJ, ZHAO Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells[J]. Nanomed-Nanotechnol, 2016, 12(3): 655-664.
|
[45] |
VIGNARD V,LABBE M,MAREC N,et al.MicroRNAs in tumor exosomes drive immune escape in melanoma[J].Cancer Immunol Res,2020,8(2):255-267.
|
[46] |
QIAN LR,DIMA DL,BERCE C,et al.Protein dysregulation in graft versus host disease[J].Oncotarget,2018,9(1):1483-1491.
|
[47] |
LENER T,GIMONA M,AIGNER L,et al.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper[J].J Extracell Vesicles,2015,4:30087.
|
[48] |
INGATO D,LEE JU,SIM SJ,et al.Good things come in small packages:Overcoming challenges to harness extracellular vesicles for therapeutic delivery[J].J Control Release,2016,241:174-185.
|